COVID19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability

Approximately 20% of the residential census at a population healthcare facility tested positive for COVID19 during the period from March 2020 through early June 2020. Individuals residing within the facility had intellectual disability, autism, and/or brain injury.   Fifteen were hospitalized, but all subsequently were discharged.  Two hospitalized clients died as a result of factors unrelated to COVID-19, aned a third was pronounced dead upon arrival at the Emergency room, again as a result of factors unrelated to COVID-19.  individuals died as a result of factors unrelated to COVID-19.  Approximately ¾ of the infected clients developed antibodies within 28 days of initial diagnosis.  The development of antibodies could not be predicted from readily available demographic or medical variables